FSK FS KKR Capital Corp

NYSE fskkradvisor.com


$ 15.52 $ 0.00 (0 %)    

Tuesday, 28-Oct-2025 07:00:00 EDT
QQQ $ 629.76 $ 0.00 (0 %)
DIA $ 478.07 $ 0.00 (0 %)
SPY $ 686.44 $ 0.00 (0 %)
TLT $ 91.81 $ 0.00 (0 %)
GLD $ 360.56 $ 0.00 (0 %)
$ 15.51
$ 15.24
$ 15.50 x 10
$ 19.00 x 500
-- - --
$ 14.05 - $ 21.74
2,256,715
na
4.34B
$ 0.69
$ 19.93
TBD
na
na ($ 0.18)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-26-2025 01-01-1970 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-26-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 02-27-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-01-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-upgrades-fs-kkr-capital-to-equal-weight-maintains-price-target-to-15

Wells Fargo analyst Finian O'Shea upgrades FS KKR Capital (NYSE:FSK) from Underweight to Equal-Weight and maintains the ...

 jp-morgan-maintains-neutral-on-fs-kkr-capital-lowers-price-target-to-15

JP Morgan analyst Richard Shane maintains FS KKR Capital (NYSE:FSK) with a Neutral and lowers the price target from $18 to $15.

 rbc-capital-maintains-sector-perform-on-fs-kkr-capital-lowers-price-target-to-18

RBC Capital analyst Kenneth Lee maintains FS KKR Capital (NYSE:FSK) with a Sector Perform and lowers the price target from $...

 keefe-bruyette--woods-maintains-market-perform-on-fs-kkr-capital-lowers-price-target-to-185

Keefe, Bruyette & Woods analyst Paul Johnson maintains FS KKR Capital (NYSE:FSK) with a Market Perform and lowers the pr...

 wells-fargo-maintains-underweight-on-fs-kkr-capital-lowers-price-target-to-15

Wells Fargo analyst Finian O'Shea maintains FS KKR Capital (NYSE:FSK) with a Underweight and lowers the price target fro...

 fs-kkr-capital-q2-adj-eps-060-misses-063-estimate-sales-39800m-miss-40254m-estimate

FS KKR Capital (NYSE:FSK) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.63 b...

 rbc-capital-maintains-sector-perform-on-fs-kkr-capital-lowers-price-target-to-21

RBC Capital analyst Kenneth Lee maintains FS KKR Capital (NYSE:FSK) with a Sector Perform and lowers the price target from $...

 fs-kkr-capital-enters-equity-distribution-agreements-agreements-allow-sale-of-up-to-750m-in-stock

-SEC Filing

 oppenheimer-maintains-perform-on-fs-kkr-capital-lowers-price-target-to-21

Oppenheimer analyst Mitchel Penn maintains FS KKR Capital (NYSE:FSK) with a Perform and lowers the price target from $22 to ...

 fs-kkr-capital-q1-adj-eps-065-beats-064-estimate-sales-40000m-beat-39472m-estimate

FS KKR Capital (NYSE:FSK) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.64 by ...

 wells-fargo-maintains-underweight-on-fs-kkr-capital-lowers-price-target-to-18

Wells Fargo analyst Finian O'Shea maintains FS KKR Capital (NYSE:FSK) with a Underweight and lowers the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION